CA Stock MarketDetailed Quotes

Biocure Technology Inc (CURE.X)

Watchlist
  • 0.035
  • 0.0000.00%
15min DelayMarket Closed Feb 26 09:30 ET
707.25KMarket Cap-3.50P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Biocure Technology Inc (CURE.X) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-658.00%-76.52K
6.24%-8.28K
-71.56%-3.8K
-304.90%-52.17K
-1,641.56%-12.28K
143.62%13.71K
-119.28%-8.83K
64.23%-2.22K
233.01%25.46K
98.64%-705
Net income from continuing operations
60.81%-102.86K
86.47%-28.38K
-421.28%-46.75K
-6.83%-21.45K
73.54%-6.29K
82.44%-262.47K
83.67%-209.68K
99.68%-8.97K
-100.75%-20.08K
71.12%-23.75K
Operating gains losses
--1.38K
----
----
----
----
----
----
----
----
----
Asset impairment expenditure
----
----
----
----
----
--0
----
----
----
----
Other non cashItems
18.09%9.12K
18.39%2.45K
18.38%2.34K
18.37%2.22K
17.11%2.11K
0.48%7.72K
-39.71%2.07K
32.71%1.98K
32.35%1.88K
33.43%1.8K
Change In working capital
-94.10%15.84K
-91.81%16.28K
750.65%40.61K
-175.46%-32.95K
-138.13%-8.1K
5.97%268.46K
59.90%198.78K
-74.42%4.77K
-46.33%43.66K
-26.79%21.25K
-Change in receivables
541.29%5.04K
85.84%-1.11K
24.41%6.01K
-112.78%-610
125.73%753
-107.41%-1.14K
-141.04%-7.82K
236.52%4.83K
-77.00%4.77K
16.85%-2.93K
-Change in prepaid assets
---1.27K
---675
----
----
----
----
----
----
----
----
-Change in payables and accrued expense
-95.52%12.07K
-91.26%18.06K
64,101.82%35.2K
-183.16%-32.34K
-136.63%-8.85K
13.31%269.6K
62.92%206.6K
-100.33%-55
-37.38%38.89K
-25.72%24.17K
Cash from discontinued investing activities
0
0
0
Operating cash flow
-658.00%-76.52K
6.24%-8.28K
-71.56%-3.8K
-304.90%-52.17K
-1,641.56%-12.28K
106.32%13.71K
-117.76%-8.83K
64.23%-2.22K
283.67%25.46K
99.71%-705
Investing cash flow
Cash flow from continuing investing activities
0
0
0
Cash from discontinued investing activities
0
0
0
Investing cash flow
----
----
--0
--0
--0
--0
--0
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
100K
0
0
0
0
0
0
Net issuance payments of debt
----
----
----
----
----
--0
----
----
----
----
Net common stock issuance
--100K
--0
--0
----
----
--0
--0
--0
----
--0
Cash from discontinued financing activities
0
0
0
Financing cash flow
--100K
--0
--0
--100K
--0
--0
--0
--0
--0
--0
Net cash flow
Beginning cash position
323.83%17.95K
85.62%49.7K
84.54%53.5K
60.65%5.67K
323.83%17.95K
-88.76%4.24K
390.40%26.78K
148.79%28.99K
-67.30%3.53K
-88.76%4.24K
Current changes in cash
71.18%23.48K
6.24%-8.28K
-71.56%-3.8K
87.86%47.83K
-1,641.56%-12.28K
141.01%13.71K
-592.31%-8.83K
64.23%-2.22K
2,846.88%25.46K
97.37%-705
Effect of exchange rate changes
----
----
--0
--0
--0
----
----
--0
--0
--0
End cash Position
130.79%41.43K
130.79%41.43K
85.62%49.7K
84.54%53.5K
60.65%5.67K
323.83%17.95K
323.83%17.95K
390.40%26.78K
148.79%28.99K
-67.30%3.53K
Free cash from
-658.00%-76.52K
6.24%-8.28K
-71.56%-3.8K
-304.90%-52.17K
-1,641.56%-12.28K
106.32%13.71K
-117.76%-8.83K
64.23%-2.22K
283.67%25.46K
99.71%-705
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -658.00%-76.52K6.24%-8.28K-71.56%-3.8K-304.90%-52.17K-1,641.56%-12.28K143.62%13.71K-119.28%-8.83K64.23%-2.22K233.01%25.46K98.64%-705
Net income from continuing operations 60.81%-102.86K86.47%-28.38K-421.28%-46.75K-6.83%-21.45K73.54%-6.29K82.44%-262.47K83.67%-209.68K99.68%-8.97K-100.75%-20.08K71.12%-23.75K
Operating gains losses --1.38K------------------------------------
Asset impairment expenditure ----------------------0----------------
Other non cashItems 18.09%9.12K18.39%2.45K18.38%2.34K18.37%2.22K17.11%2.11K0.48%7.72K-39.71%2.07K32.71%1.98K32.35%1.88K33.43%1.8K
Change In working capital -94.10%15.84K-91.81%16.28K750.65%40.61K-175.46%-32.95K-138.13%-8.1K5.97%268.46K59.90%198.78K-74.42%4.77K-46.33%43.66K-26.79%21.25K
-Change in receivables 541.29%5.04K85.84%-1.11K24.41%6.01K-112.78%-610125.73%753-107.41%-1.14K-141.04%-7.82K236.52%4.83K-77.00%4.77K16.85%-2.93K
-Change in prepaid assets ---1.27K---675--------------------------------
-Change in payables and accrued expense -95.52%12.07K-91.26%18.06K64,101.82%35.2K-183.16%-32.34K-136.63%-8.85K13.31%269.6K62.92%206.6K-100.33%-55-37.38%38.89K-25.72%24.17K
Cash from discontinued investing activities 000
Operating cash flow -658.00%-76.52K6.24%-8.28K-71.56%-3.8K-304.90%-52.17K-1,641.56%-12.28K106.32%13.71K-117.76%-8.83K64.23%-2.22K283.67%25.46K99.71%-705
Investing cash flow
Cash flow from continuing investing activities 000
Cash from discontinued investing activities 000
Investing cash flow ----------0--0--0--0--0--0--0--0
Financing cash flow
Cash flow from continuing financing activities 100K000000
Net issuance payments of debt ----------------------0----------------
Net common stock issuance --100K--0--0----------0--0--0------0
Cash from discontinued financing activities 000
Financing cash flow --100K--0--0--100K--0--0--0--0--0--0
Net cash flow
Beginning cash position 323.83%17.95K85.62%49.7K84.54%53.5K60.65%5.67K323.83%17.95K-88.76%4.24K390.40%26.78K148.79%28.99K-67.30%3.53K-88.76%4.24K
Current changes in cash 71.18%23.48K6.24%-8.28K-71.56%-3.8K87.86%47.83K-1,641.56%-12.28K141.01%13.71K-592.31%-8.83K64.23%-2.22K2,846.88%25.46K97.37%-705
Effect of exchange rate changes ----------0--0--0----------0--0--0
End cash Position 130.79%41.43K130.79%41.43K85.62%49.7K84.54%53.5K60.65%5.67K323.83%17.95K323.83%17.95K390.40%26.78K148.79%28.99K-67.30%3.53K
Free cash from -658.00%-76.52K6.24%-8.28K-71.56%-3.8K-304.90%-52.17K-1,641.56%-12.28K106.32%13.71K-117.76%-8.83K64.23%-2.22K283.67%25.46K99.71%-705
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -